Assyro AI

FDA Orange Book · active-ingredient family

Sulfur hexafluoride lipid-type a microspheres

Sulfur hexafluoride lipid-type a microspheres is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:LUMASON · NDA 203684

1

Brand (NDA)

0

Generics (ANDA)

3

Listed patents

0

Exclusivity periods

Brand (NDA) products · for suspension

ProductApplicantApplicationTEApproved
LUMASONRLDBRACCONDA 203684Oct 15, 2014

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10232061Jul 06, 2038in 12 yr 3 mo
Product
10335502Jul 06, 2038in 12 yr 3 mo
Product
11723869May 15, 2039in 13 yr 1 mo
ProductU-3666

Sulfur hexafluoride lipid-type a microspheres — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.